HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken L Chambliss Selected Research

Neuroinflammatory Diseases

11/2018Selective Nonnuclear Estrogen Receptor Activation Decreases Stroke Severity and Promotes Functional Recovery in Female Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken L Chambliss Research Topics

Disease

4Obesity
12/2019 - 08/2014
4Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 02/2008
4Breast Neoplasms (Breast Cancer)
11/2018 - 07/2010
3Atherosclerosis
01/2019 - 10/2002
3Neoplasms (Cancer)
11/2018 - 08/2014
3Insulin Resistance
01/2018 - 01/2016
3Type 2 Diabetes Mellitus (MODY)
01/2016 - 06/2009
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021 - 10/2018
2Hypertension (High Blood Pressure)
12/2019 - 02/2015
2Infarction (Infarctions)
11/2018 - 01/2017
1Pre-Eclampsia (Preeclampsia)
01/2021
1Myocardial Infarction
01/2019
1Neuroinflammatory Diseases
11/2018
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2018
1Stroke (Strokes)
11/2018
1Thrombosis (Thrombus)
10/2018
1Weight Gain
01/2018
1Reperfusion Injury
01/2017
1Body Weight (Weight, Body)
08/2014
1Fatty Liver
08/2014
1Endometrial Neoplasms (Endometrial Cancer)
07/2010
1Hyperplasia
07/2010
1Electric Injuries
01/2006
1Vascular Diseases (Vascular Disease)
01/2006
1Vascular System Injuries
10/2002

Drug/Important Bio-Agent (IBA)

4Estrogens (Estrogen)FDA Link
11/2018 - 10/2002
4Estradiol (Delestrogen)FDA LinkGeneric
11/2018 - 07/2010
4Glucose (Dextrose)FDA LinkGeneric
01/2018 - 08/2014
4C-Reactive ProteinIBA
01/2016 - 06/2009
3IgG Receptors (Fc gamma RI)IBA
12/2019 - 02/2015
3Immunoglobulin G (IgG)IBA
12/2019 - 02/2015
3Insulin (Novolin)FDA Link
01/2018 - 06/2009
2N-acetylmannosamineIBA
12/2019 - 01/2018
2N-Acetylneuraminic Acid (Sialic Acid)IBA
12/2019 - 01/2018
2Scavenger Receptors (Scavenger Receptor)IBA
01/2019 - 02/2008
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2018 - 01/2016
2Estrogen Receptor alphaIBA
01/2017 - 07/2010
2Nitric Oxide Synthase (NO Synthase)IBA
02/2015 - 02/2008
2HDL CholesterolIBA
02/2008 - 01/2006
2HDL LipoproteinsIBA
02/2008 - 01/2006
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2021
1oxidized low density lipoproteinIBA
01/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2019
1Transcription Factors (Transcription Factor)IBA
11/2018
1Estrogen ReceptorsIBA
11/2018
1(S)- 5- (4- hydroxy- 3,5- dimethyl- phenyl)- indan- 1- olIBA
11/2018
1low density lipoprotein receptor-related protein 8IBA
10/2018
1Antiphospholipid AntibodiesIBA
10/2018
1Glycoproteins (Glycoprotein)IBA
10/2018
1LigandsIBA
01/2018
1AminesIBA
10/2016
1Apolipoproteins E (ApoE)IBA
10/2016
1Ethinyl Estradiol (Estinyl)FDA LinkGeneric
10/2016
1Dendrimers (Dendrons)IBA
10/2016
1Serum Amyloid P-ComponentIBA
02/2015
1Selective Estrogen Receptor Modulators (SERM)IBA
08/2014
1bazedoxifeneIBA
08/2014
1SteroidsIBA
08/2014
1Conjugated (USP) Estrogens (Premarin)FDA Link
08/2014
1GTP-Binding Proteins (G-Protein)IBA
07/2010
1Acute-Phase Proteins (Acute-Phase Protein)IBA
06/2009
1high density lipoprotein receptorsIBA
02/2008
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2006

Therapy/Procedure

1Therapeutics
10/2016